BioMarin Pharmaceutical: Kursziel erhöht
San Francisco (www.aktiencheck.de) - Rating-Update:
Die Einschätzung von Mohit Bansal, Analyst von Wells Fargo Advisors, für die Aktie von BioMarin Pharmaceutical…
63,448$
Echtzeit-Aktienkurs Biomarin Pharmaceutical Inc.
Bid:
Ask:
Nachrichten zur Biomarin Pharmaceutical Inc. Aktie
BioMarin Pharmaceutical, Inc. (BMRN) Q1 2024 Earnings Call Transcript
…
BioMarin Pharmaceutical Inc. 2024 Q1 - Results - Earnings Call Presentation
…
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
BioMarin (BMRN) delivered earnings and revenue surprises of 18.33% and 0.14%, respectively, for the quarter ended March 2024. Do the…
GMAB: 3 Biotech Stocks Gaining Altitude and Interest
This year, the biotech industry anticipates a resurgence with increased M&A, FDA approvals, and AI-driven innovations. Given the industry’s rosy…
BioMarin Pharmaceutical: Still Has A Lot Of Room For Growth
…